Showing results (11-20 of 72) with videos related to
Sort By:
Pageof 8
Clinical Pharmacokinetics|August 10, 2002
Oral bioavailability of desloratadine is unaffected by foodSamir Gupta, Christopher Banfield, Melton Affrime, et al.Clinical Drug Investigation|September 2, 2018
Open-Label Single-Dose Study to Assess the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of MirogabalinKenneth Duchin, Giorgio Senaldi, Vance Warren, et al.Journal of Clinical Pharmacology|November 7, 2021
Pharmacokinetics and Safety of Intravenous Ferric Pyrophosphate Citrate: Equivalence to Administration via DialysateThomas Marbury, Fred van Heuveln, Eric van der Horst, et al.Headache|May 15, 2009
Zelrix: a novel transdermal formulation of sumatriptanMark Pierce, Thomas Marbury, Carol O'Neill, et al.Therapeutic Drug Monitoring|March 2, 2016
A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal FunctionJames Ermer, Mary Corcoran, Kenneth Lasseter, et al.Clinical Pharmacology in Drug Development|December 21, 2018
Elagolix Pharmacokinetic Profiles in Women With Renal or Hepatic ImpairmentJuki Ng, W Rachel Duan, Thomas Marbury, et al.Journal of Clinical Pharmacology|April 1, 2020
Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal ImpairmentMarcus-Hillert Schultze-Mosgau, Kenneth C Lasseter, Thomas Marbury, et al.Antimicrobial Agents and Chemotherapy|June 19, 2002
Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trialsSpotswood L Spruance, Robert Nett, Thomas Marbury, et al.Current Medical Research and Opinion|March 16, 2007
Garenoxacin pharmacokinetics in subjects with renal impairmentGopal Krishna, Diptee Gajjar, Suzanne Swan, et al.Pharmacotherapy|June 6, 2024
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjectsShawn Flanagan, Voon Ong, Thomas Marbury, et al.Pageof 8